Back to search

Article

Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer

2020-02-04

Abstract excerpt

<h4>ABSTRACT</h4> <h4>PURPOSE</h4> Estrogen receptor (ER) positive breast cancer is frequently sensitive to endocrine therapy. Multiple mechanisms of endocrine therapy resistance have been identified, including cancer stem-like cell (CSC) activity. Sulforaphane (SFN) has previously been shown to target CSCs but its mechanism of action is unclear. Here we investigate SFX-01, a stabilised formulation of SFN, for i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52b16fcc-07d9-533b-a2ce-87f103136a18
DOI
10.1101/2020.02.03.932194
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancerDOI 10.1101/2020.02.03.932194
Select a neighboring publication to make it the new centre.